BIOMAT Database Logo BIOMAT Database Logo

Conformational and dynamic considerations in the design of peptide hormone analogs. 1983

V J Hruby, and H I Mosberg, and T K Sawyer, and J J Knittel, and T W Rockway, and J Ormberg, and P Darman, and W Y Chan, and M E Hadley

UI MeSH Term Description Entries
D009074 Melanocyte-Stimulating Hormones Peptides with the ability to stimulate pigmented cells MELANOCYTES in mammals and MELANOPHORES in lower vertebrates. By stimulating the synthesis and distribution of MELANIN in these pigmented cells, they increase coloration of skin and other tissue. MSHs, derived from pro-opiomelanocortin (POMC), are produced by MELANOTROPHS in the INTERMEDIATE LOBE OF PITUITARY; CORTICOTROPHS in the ANTERIOR LOBE OF PITUITARY, and the hypothalamic neurons in the ARCUATE NUCLEUS OF HYPOTHALAMUS. MSH,Melanocyte Stimulating Hormone,Melanocyte-Stimulating Hormone,Melanophore Stimulating Hormone,Melanotropin,MSH (Melanocyte-Stimulating Hormones),Melanophore-Stimulating Hormone,Hormone, Melanocyte Stimulating,Hormone, Melanocyte-Stimulating,Hormone, Melanophore Stimulating,Melanocyte Stimulating Hormones,Stimulating Hormone, Melanocyte,Stimulating Hormone, Melanophore
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

V J Hruby, and H I Mosberg, and T K Sawyer, and J J Knittel, and T W Rockway, and J Ormberg, and P Darman, and W Y Chan, and M E Hadley
Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerations.
June 1990, The Biochemical journal,
V J Hruby, and H I Mosberg, and T K Sawyer, and J J Knittel, and T W Rockway, and J Ormberg, and P Darman, and W Y Chan, and M E Hadley
Conformational considerations in the design of glucagon agonists and antagonists: examination using synthetic analogs.
January 1986, Biopolymers,
V J Hruby, and H I Mosberg, and T K Sawyer, and J J Knittel, and T W Rockway, and J Ormberg, and P Darman, and W Y Chan, and M E Hadley
Conformational analysis of cyclic opioid peptide analogs.
January 1988, NIDA research monograph,
V J Hruby, and H I Mosberg, and T K Sawyer, and J J Knittel, and T W Rockway, and J Ormberg, and P Darman, and W Y Chan, and M E Hadley
Amphiphilic growth hormone releasing factor (GRF) analogs: peptide design and biological activity in vivo.
September 1986, Biochemical and biophysical research communications,
V J Hruby, and H I Mosberg, and T K Sawyer, and J J Knittel, and T W Rockway, and J Ormberg, and P Darman, and W Y Chan, and M E Hadley
Acidic analogs of the luteinizing hormone-releasing hormone and conformational aspects for activity.
April 1974, Biochemical and biophysical research communications,
V J Hruby, and H I Mosberg, and T K Sawyer, and J J Knittel, and T W Rockway, and J Ormberg, and P Darman, and W Y Chan, and M E Hadley
Peptide dynamic fingerprints: a tool for investigating the role of conformational flexibility for GLP-1 analogs affinity.
July 2005, Journal of peptide science : an official publication of the European Peptide Society,
V J Hruby, and H I Mosberg, and T K Sawyer, and J J Knittel, and T W Rockway, and J Ormberg, and P Darman, and W Y Chan, and M E Hadley
Conformational analysis of opioid peptides and the use of conformational restriction in the design of selective analogs.
January 1986, NIDA research monograph,
V J Hruby, and H I Mosberg, and T K Sawyer, and J J Knittel, and T W Rockway, and J Ormberg, and P Darman, and W Y Chan, and M E Hadley
Conformational comparisons of a series of tachykinin peptide analogs.
December 2007, Journal of medicinal chemistry,
V J Hruby, and H I Mosberg, and T K Sawyer, and J J Knittel, and T W Rockway, and J Ormberg, and P Darman, and W Y Chan, and M E Hadley
Conformational and topographical considerations in the design of biologically active peptides.
July 1993, Biopolymers,
V J Hruby, and H I Mosberg, and T K Sawyer, and J J Knittel, and T W Rockway, and J Ormberg, and P Darman, and W Y Chan, and M E Hadley
Transducer design considerations in dynamic focusing.
January 1979, Ultrasound in medicine & biology,
Copied contents to your clipboard!